Iridex (IRIX) FCF Margin Growth (3y) (2014 - 2026)
Iridex (IRIX) FCF Margin Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 884.00 |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 534.00 |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 919.00 |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 3,472.00 |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | -97.00 |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 413.00 |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | -63.00 |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 60.00 |
| 10 | Iridex | 13.03 Mn | 8.35 Mn | 4.30 Mn | 1,136.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 889.00 |
| Jan 3, 2026 | 1,725.00 |
| Sep 27, 2025 | 869.00 |
| Jun 28, 2025 | 1,844.00 |
| Mar 29, 2025 | 1,564.00 |
| Dec 28, 2024 | -4,801.00 |
| Mar 30, 2024 | -11,340.00 |
| Sep 30, 2023 | -2,079.00 |
| Jul 1, 2023 | 2,438.00 |
| Apr 1, 2023 | -507.00 |
| Dec 31, 2022 | -954.00 |
| Oct 1, 2022 | 601.00 |
| Jul 2, 2022 | -804.00 |
| Apr 2, 2022 | 1,126.00 |
| Jan 1, 2022 | 5,825.00 |
| Apr 3, 2021 | 12,833.00 |
| Sep 26, 2020 | 1,865.00 |
| Jun 27, 2020 | -4,116.00 |
| Mar 28, 2020 | 274.00 |
| Dec 28, 2019 | 323.00 |